Chronic graft-versus-host disease (cGVHD) is a common side effect of allogeneic stem cell
transplantation and a major cause of morbidity and mortality in affected patients. Especially …

Abstract Systemic sclerosis (scleroderma)(SSc) is a rare autoimmune disorder characterized
by excessive production of collagen. Extracorporeal photopheresis (photochemotherapy …

Extracorporeal photochemotherapy (ECP) is a treatment approved by the FDA for cutaneous
T‐cell lymphoma, and it is currently used off‐label for graft‐versus‐host disease (GvHD) and …

Photopheresis is a form of phototherapy where specialized equipment is used to isolate a
leukocyte fraction from the peripheral blood which is then exposed to photoactivated 8 …

Graft versus host disease (GVHD) is still the most important cause of mortality and morbidity
after allogeneic stem cell transplantation. Though perfect response rates are not achieved …

Since its introduction in photomedicine in 1983 ECP (extracorporeal photopheresis) has
over the past decades been established as a safe and effective treatment approach for the …

Objectives Chronic graft versus host disease (chronic GVHD) still remains the leading cause
of late morbidity and mortality for allogeneic hematopoietic stem cell transplant (allo-HSCT) …

Background and Objectives Extracorporeal photochemotherapy (ECP) is an established
therapy in various diseases, such as cutaneous T‐cell lymphoma and graft‐versus‐host …

Extracorporeal photopheresis (ECP) is a combination of leukapheresis and photodynamic
therapy in which blood is treated with photoactivable drugs which are then activated with …

Background The addition of extracorporeal photochemotherapy (ECP) to standard
immunosuppressive therapy has been suggested to be beneficial in the treatment of …